Glomerulosclerosis, a final common lesion of various glomerular diseases, is characterized by mesangial cell proliferation and extracellular matrix (ECM) expansion. TGF-ft and PDGF are known to play a critical role in the regulation of ECM metabolism and mesenchymal cell proliferation, respectively. However, there is little evidence to demonstrate the direct role ofeach of these growth factors in the pathogenesis ofglomerulosclerosis. Using an in vivo transfection technique, we could realize the selective overexpression of single growth factor in the kidney. The introduction of either TGF-,8 or PDGF-B gene alone into the kidney induced glomerulosclerosis, although the patterns ofaction ofthese growth factors were different; TGF-ft affected ECM accumulation rather than cell proliferation and PDGF affected the latter rather than the former. (J. Clin. Invest. 1993Invest. . 92:2597Invest. -2601
Introduction
Glomerulosclerosis is considered to be the final common pathway leading to the progressive loss of renal function in various types of primary glomerulonephritis, diabetic nephropathy, and lupus nephritis. A variety ofin vitro studies have suggested that growth factors, especially TGF-f3 ( 1, 2) and PDGF (3) (4) (5) , contribute to the pathophysiological process in the development ofglomerulosclerosis characterized by mesangial cell proliferation and extracellular matrix (ECM)' expansion. Furthermore, the pathogenetic involvement of these growth factors in experimental glomerulonephritis has been shown in vivo, if not directly: Both factors were highly expressed in diseased glomeruli (6) (7) (8) and antiserum against TGF-3 (9) or PDGF-B ( 10) could suppress the disease progression in anti-Thy 1 experimental glomerulonephritis. Nevertheless, it still remains obscure whether TGF-f or PDGF plays a direct role in vivo in the Address correspondence to Dr. Enyu Imai, First Department of Medicine, Osaka University Medical School, 2-2, Yamada-Oka, Suita-city, Osaka 565, Japan.
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1. Abbreviations used in this paper: CAT, chloramphenicol acetyltransferase; ECM, extracellular matrix; HMG-1, high mobility group Histological analysis. Animals were sacrificed under sodium pentobarbital (50 mg/kg, i.p.) anesthesia on day 3, 5, and 7 after the introduction and both kidneys were fixed for light micrography and immunofluorescence. At least six rats were examined for each expression vector in each time point. For immunohistochemistry, the kidneys were fixed in buffered formaldehyde and 5-yrm-thick cryostat sections were blocked with 5% normal sheep serum in PBS for 30 min, incubated with first antibody for 1 h, and incubated with second antibody (fluorescein-conjugated sheep antibody against rabbit IgG; Silenus Laboratory, Hawthorn, Victoria, Australia) for 30 min at room temperature. To confirm the expression ofthe introduced cDNAs, rabbit antihuman TGF,61 and rabbit anti-human PDGF-B (both from King Brewing Co., LTD., Kakogawa, Japan) were used as first antibodies. These antibodies crossreact to rat TGF-,B1 and PDGF-B, respectively.
To estimate the transfection efficiency, rabbit anti-CAT (5Prime -P 3Prime, Inc., Boulder, CO) were used as first antibodies, and CATpositive glomeruli were counted. To examine the proliferating cells, mouse antibody to proliferating cell nuclear antigen (PCNA; Coulter Clone, Hialeah, FL), which is a cell proliferation marker, and EDi (Serotec LTD, Oxford, UK), mouse antibody to rat monocyte and macrophages, were used as first antibodies. For light microscopy, tissues were fixed in neutral formalin and enbedded in paraffin, and 2-Mgm sections were stained with periodic acid-Schiff. To quantitate mesangial matrix expansion and glomerular cell counts, all sections were read by an observer unaware of the experimental protocol. 30 glomeruli (80-100 Mm in diameter) were selected at random in sections from rats on day 3, 5, and 7 after introduction ofcontrol CAT, TGF#1, or PDGF gene. The degree of glomerular matrix expansion was determined by Raij's method ( 17) . For the qualitative analysis of the accumulated matrix, rabbit antibodies to collagen type I, III, IV, which were gifts from Dr. Ohshima (Department of Pathology, Wakayama Medical College, Wakayama, Japan) were used as first antibodies ofthe immunofluorescence. TGF-# I nor PDGF-B was expressed in the kidney after CAT gene was introduced. This implies that human TGF-f31 or PDGF-B was highly expressed in the glomeruli as a single autocrine and/or paracrine factor. We evaluated, histological disease activity on 3, 5, and 7 d after gene introduction. A pathological alteration of the glomeruli was present in all of the rats transfected with either TGF-, 1 or PDGF-B gene. Fig. 2 shows representative photomicrographs of glomeruli from transfected rats. In the TGF-fl 1 gene-transfected rats, an extensive ECM expansion with a moderate mesangial cell proliferation was observed. In contrast, the major alteration in the PDGF-B gene transfected rats was a striking increase in cellularity with an ECM expansion. It is worthy of note that the conspicuous lobular architecture ofthe tufts, which sometimes leads to the formation ofprominent nodules, was shown in this group.
Results

TGF-# 1 or PDGF-B was detected immunohistochemically
The quantitated data on glomerular ECM expansion and mesangial cell proliferation are summarized in Fig. 3 . Glomerular cell counts were increased to 115% and 145% of the control level (determined in the experiment using CAT gene) by TGF-1 I and PDGF-B, respectively. No proliferative change was seen in glomeruli of right kidneys of TGF-,B-or PDGFtransfected rats. To confirm the mesangial cell proliferation, the left kidneys were examined immunohistochemically with anti-PCNA and anti-ED1 antibodies. The PCNA-positive cells were significantly increased in the glomeruli from PDGF or TGF-# introduced rats, while ED 1-positive cell number was unchanged. Polymorphonuclear cells were not infiltrated in the transfected kidney. These results suggest that the glomerular hypercellularity seems to result from the resident mesangial cells. The qualitative analysis of the ECM accumulated in the sclerotic lesion using several antibodies to collagens showed that TGF-# increased the contents of type I and type III collagens mainly in the mesangial area and appeared to produce a slight increase in type IV collagen, whereas the introduction of CAT had virtually no effects on collagen contents (Fig. 4) .
Neither serum creatinine nor urea nitrogen was increased in all transfected rats. Pathological proteinuria was present in both TGF-# gene-and PDGF-B gene-transfected rats, while pathological proteinuria was absent in the CAT gene-transfected rats. The hallmark ofthe progressive glomerular damage is sclerosis. Sclerotic alterations in the glomeruli are believed to develop very slowly in the course ofchronic glomerulonephritis. Immunological injury, lasting glomerular hypertension, and/or precedent glomerular hypertrophy are supposed to be triggers leading to eventual glomerulosclerosis. Surprisingly, in this study the pathological changes of the glomerulus took place within a week after transfection without a drastic precedent event like mesangiolysis in anti-Thy 1 glomerulonephritis. Here we propose a hypothesis that TGF-(3 and PDGF play a primary role in the development of glomerulosclerosis; whatever triggers may increase glomerular TGF-(3 and/or PDGF production, overexpressed TGF-# and PDGF appear to accomplish the sclerotic change in the glomerulus in a short period even in the absence ofabnormal physical force or immunological insults.
In this study the prominent change induced by TGF-# I was ECM expansion and that induced by PDGF-B was cell proliferation. There remains a possibility that PDGF may stimulate mesangial cells to release autocrine TGF-(3 and that TGF-j3 may also induce PDGF. However, TGF-,B was not detected immunohistochemically in the kidney from the transfected PDGF gene and vice versa. Thus, it is likely that the overex- (20) ; a low concentration promotes cell proliferation and a high concentration suppresses it. In the meantime, an elevated local expression of TGF-1 1 induced mesangial cell proliferation in the present in vivo experiment. The dual property of the growth factor may be dependent on the cellular milieu and the growth-promoting function may be preponderant in vivo.
The elevated expression ofPDGF-B in vivo caused a proliferative change with a striking increase in cellularity and a relatively weak ECM accumulation. Up-regulation of the PDGF receptor may be a prerequisite to mesangial cell proliferation induced by overexpressed PDGF. The PDGF receptor /3 subunit expression is known to be up-regulated in the experimental Thy-1 glomerulonephritis model (7). PDGF receptor 13 is reportedly up-regulated in response to PDGF-B in an in vitro system (22, 23) . The transient up-regulation ofPDGF receptor due to PDGF-B overexpression gave a basis for the postulate that there exists a positive feedback mechanism, which can explain, in part, the reason why overexpressed PDGF-B exerted a strong proliferating action in the glomeruli.
In the present in vivo murine study we could introduce the exogeneous gene selectively into the rat kidney via the renal artery. Furthermore, our method itself is considered harmless, because neither histological changes nor pathological proteinuria were recognized in the control animals which received CAT gene. This HVJ-liposome method permits efficient selective gene transfer into the kidney, neither exerting a cytotoxic action nor giving immunological stimulation, and it can be a useful tool for studying the action of each individual growth factor in the kidney in situ.
